Bolei Dai
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 3
- interferon and immune responses 1
-
- RNA modifications and cancer 2
- Co-authors
- Zhihong Zhang (7 shared papers)Qingming Luo (4 shared papers)Xiang Yu (2 shared papers)Guoqiang Xu (2 shared papers)Lisen Lu (1 shared paper)Yuan Qian (1 shared paper)Yanfeng Dai (1 shared paper)Sha Qiao (1 shared paper)
- Journals
- Theranostics (3 papers)ACS Nano (2 papers)Biomolecules (1 paper)Nature Communications (1 paper)Antioxidants (1 paper)
- Partner nations
- China
In The Last Decade
Bolei Dai
11 papers receiving 497 citations
Peers
Comparison fields: 5 of 57
- Immunology 281
- Biomaterials 74
- Biomedical Engineering 224
- Oncology 101
- Cancer Research 49
Countries citing papers authored by Bolei Dai
This map shows the geographic impact of Bolei Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolei Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolei Dai more than expected).
Fields of papers citing papers by Bolei Dai
This network shows the impact of papers produced by Bolei Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolei Dai. The network helps show where Bolei Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Bolei Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 300 | |
| 2 | 2019 | 119 | |
| 3 | 2019 | 20 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 12 | |
| 6 | 2022 | 11 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2024 | 2 |
About Bolei Dai
Bolei Dai is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Cancer Research, having authored 11 papers that have together received 500 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Phagocytosis and Immune Regulation (3 papers), Photoacoustic and Ultrasonic Imaging (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers), interferon and immune responses (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Immunology (281 citations), Biomaterials (74 citations), Biomedical Engineering (224 citations), Oncology (101 citations) and Cancer Research (49 citations). Bolei Dai has collaborated with scholars based in China. Frequent co-authors include Zhihong Zhang, Qingming Luo, Xiang Yu, Guoqiang Xu, Lisen Lu, Yuan Qian, Yanfeng Dai, Sha Qiao, Jianqiao Liu and Guanxin Shen. Their work appears in journals such as Theranostics, ACS Nano, Biomolecules, Nature Communications and Antioxidants.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.